EcoDrugPlus

Transthyretin

Ensembl ID : ENSMAMG00000006873
Gene Symbol: TTR
3 Cross references
178 Possible Orthologues:

Tryptophan Hydroxylase 1 (Tryptophan 5-Monooxygenase) A

Ensembl ID : ENSMAMG00000003586
Gene Symbol: TPH1A
3 Cross references
207 Possible Orthologues:

Ttk Protein Kinase

Ensembl ID : ENSMAMG00000001935
Gene Symbol: TTK
3 Cross references
204 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSMAMG00000019003
Gene Symbol: TUBA4A
3 Cross references
155 Possible Orthologues:

Tubulin Alpha-1b Chain

Ensembl ID : ENSMAMG00000004189
Gene Symbol: LOC113146169
2 Cross references
190 Possible Orthologues:

Tubulin Alpha-1c Chain-Like

Ensembl ID : ENSMAMG00000022369
Gene Symbol: LOC113127458
3 Cross references
169 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSMAMG00000013990
Gene Symbol: LOC113126035
2 Cross references
178 Possible Orthologues:

Tubulin Beta-2a Chain-Like

Ensembl ID : ENSMAMG00000026660
Gene Symbol: LOC113134926
3 Cross references
305 Possible Orthologues:

Tubulin, Beta 1 Class Vi

Ensembl ID : ENSMAMG00000009479
Gene Symbol: TUBB1
2 Cross references
184 Possible Orthologues:

Tubulin, Beta 4b Class Ivb-Like

Ensembl ID : ENSMAMG00000026174
Gene Symbol: TUBB4BL
2 Cross references
174 Possible Orthologues:

Tubulin, Beta 5

Ensembl ID : ENSMAMG00000003772
Gene Symbol: TUBB5
2 Cross references
173 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSMAMG00000003571
Gene Symbol: TP53
2 Cross references
232 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).